5-Fluorouracil:identification of novel downstream mediators of tumour response
| Data(s) |
2004
|
|---|---|
| Resumo |
5-Fluorouracil (5-FU) is routinely used in the treatment of gastrointestinal, breast and head and neck cancers. A major limitation to the use of this drug is acquired or inherent resistance. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Boyer , J , Maxwell , P J , Longley , D B & Johnston , P G 2004 , ' 5-Fluorouracil : identification of novel downstream mediators of tumour response ' Anticancer Research , vol 24 , no. 2A , pp. 417-23 . |
| Tipo |
article |
